AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...
IEEE

Suitability Analysis of Inverter Topologies and Their Modulation Strategies for Two-Phase Bearingless Motors

Abstract: Different from the traditional three-phase form of the bearingless motor (BM), the two-phase form of BM has unique advantages in sensor assembly and signal interpretation. As the current ...
Investing.com India

Vanda Pharmaceuticals stock falls after FDA rejects jet lag treatment application

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock fell 12% Thursday morning after the company announced that the U.S. Food and Drug Administration (FDA) rejected its application for HETLIOZ ...
Careerindia

SEBI Grade A Admit Card 2026 Released for Phase 1 Exam; Download at sebi.gov.in

SEBI Grade A Admit Card 2026 for Phase 1 exam has been released at sebi.gov.in. The exam will be held on January 10, 2026. Check download link, exam date, documents required, and instructions here.
The Indianapolis Star

Short-Form Drama Enters a New Phase: Zhou Lingyi’s ‘Content Reconstruction Theory’ Resonates Across the Industry

Zhou Lingyi’s “Content Reconstruction Theory” represents an evolution in creative logic, returning short-form dramas to the fundamental task of storytelling. “Future short-form dramas will not compete ...